Zobrazeno 1 - 10
of 272
pro vyhledávání: '"Volker Vallon"'
Autor:
Takahiro Masuda, Shigeaki Muto, Keiko Fukuda, Minami Watanabe, Ken Ohara, Hermann Koepsell, Volker Vallon, Daisuke Nagata
Publikováno v:
Physiological Reports, Vol 8, Iss 2, Pp n/a-n/a (2020)
Abstract Most of the filtered glucose is reabsorbed in the early proximal tubule by the sodium‐glucose cotransporter SGLT2. The glycosuric effect of the SGLT2 inhibitor ipragliflozin is linked to a diuretic and natriuretic effect that activates com
Externí odkaz:
https://doaj.org/article/7f897b7c175e45e0a5eefad60dc7a9bc
Publikováno v:
American Journal of Physiology-Renal Physiology. 324:F544-F557
This study provides new insights into kidney gene expression of leptin receptor splice variants, leptin-sensitive kidney gene expression, and the role of the leptin receptor in renal tubular cells for the response to diet-induced hyperleptinemia and
Autor:
Aleix, Navarro Garrido, Young Chul, Kim, Yuji, Oe, Haiyan, Zhang, Maria, Crespo-Masip, Helen A, Goodluck, Sadhana, Kanoo, Paul W, Sanders, Stefan, Bröer, Volker, Vallon
Publikováno v:
American journal of physiology. Renal physiology. 323(4)
B
Publikováno v:
American journal of physiology. Renal physiology. 323(3)
In nondiabetic rats, the Na+-glucose cotransporter 2 (SGLT2) inhibitor ipragliflozin increased vasopressin-related stimulation of fluid intake and free water reabsorption and maintained fluid balance and serum creatinine, whereas the loop diuretic fu
Publikováno v:
Nephron. :1-20
Introduction: Agonists of soluble guanylate cyclase (sGC) are being developed as treatment for cardiovascular disease. Most effects of nitric oxide (NO) on glomerular and tubular function are mediated through sGC, but whether sGC agonists mimic these
Autor:
Aleix Navarro Garrido, Young Chul Kim, Yuji Oe, Haiyan Zhang, Maria Crespo-Masip, Helen A. Goodluck, Sadhana Kanoo, Paul W. Sanders, Stefan Bröer, Volker Vallon
Publikováno v:
American Journal of Physiology-Renal Physiology. 323:F455-F467
Based on insights from studies manipulating glucose transport, the hypothesis has been proposed that inhibiting intestinal uptake or renal reabsorption of energy substrates has unique therapeutic potential to improve metabolic disease and kidney outc
Autor:
Volker Vallon
Publikováno v:
Heart Failure Clinics. 18:539-549
SGLT2 inhibitors can protect the kidneys of patients with and without type 2 diabetes from failing. This includes blood glucose dependent and independent mechanisms. SGLT2 inhibitors lower glomerular pressure and filtration, thereby reducing the phys
Autor:
Shilpa Sharma, Ronit Katz, Charles Ginsberg, Alexander Bullen, Volker Vallon, Scott Thomson, Orson W. Moe, Andrew N. Hoofnagle, Peter W. de Leeuw, Abraham A. Kroon, Alfons J.H.M. Houben, Joachim H. Ix
Publikováno v:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, vol 37, iss 6
Journal of Bone and Mineral Research, 37(6), 1170-1178. Wiley
Journal of Bone and Mineral Research, 37(6), 1170-1178. Wiley
Relative abundance of fibroblast growth factor-23 (FGF23) measured by the C-terminal (cFGF23, which measures both intact FGF23 and C-terminal fragments) versus intact (iFGF23, measures only intact hormone) assays varies by kidney function in humans.
Autor:
Yuji Oe, Young Chul Kim, Sadhana Kanoo, Helen A Goodluck, Natalia Lopez, Pamela Maher, Volker Vallon
Publikováno v:
Physiology. 38
Aristolochic acid (AA) ingestion causes Balkan nephropathy, characterized by tubular injury and progression to chronic kidney disease (CKD). AA is taken up by proximal tubule cells via organic anion transport (OAT3) and induces p53-mediated DNA damag